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2007 in Philadelphia, Pennsylvania.
David Nash, MD, MBA: First of all, I want to
thank all of you for joining me on this call. I’d
like to turn first to Dr. Don Wilson. Don, you
moderated the Health Information Technology
(HIT) for the Consumer session. We’re anxious
to hear your review.
Donald F. Wilson, MD: I think we had a great
session. It was well attended, and we had lots
of good participation, lots of questions from the
audience, and dialogue back and forth. I’ll go
through each session and provide a synopsis of
what happened.
The first session was entitled “Consumer 
Engagement: Personalized Information and
Whole Person Health,” and was presented by
Dr. Dexter Shurney of Healthways. Basically
that session dealt with using the fact that HIT
can help promote self-care; HIT can be used as
a way of engaging and motivating consumers
to reduce their risks and to modify their be-
haviors. This is, as we all know, a big piece of
what really drives the whole disease manage-
ment process. They’re actually improving peo-
ple’s health and reducing health care costs.
Dr. Shurney talked about the fact that the
benefits include decreased medical costs, de-
creased absenteeism, and increased productiv-
ity, so HIT does more than just improve over-
all medical care. There are many other positive
benefits in addition to those.
He talked about the fact that you can use HIT
not only to engage people to increase their own
self-care, but also to actually teach patients the
guidelines for their conditions. There really
shouldn’t be any inhibitions about providing
patients with care guidelines so that they can
use them to better direct their own care.
Dr. Shurney talked about the fact that HIT
can be used to create the “veto rule,” as I think
he called it. This means helping to empower
patients to be able to make decisions about
health care that they may not need. An inter-
active guide is available to help a patient de-
cide whether he or she should have surgery for
back pain, for example. The guide helps pa-
tients to make their own decisions about how
they feel about it.
And again, the whole concept is to encour-
age consumers to be proactive in their health
care. I thought it was a great session.
The second session was on “Personal Health
Records,” and was presented by Dr. David Ah-
ern of Brigham and Women’s Hospital and Dr.
Charles Eaton of Brown Medical School. They
talked about a pilot project that they’re work-
ing on at Memorial Hospital in Rhode Island.
They have GE Centricity as their electronic
medical record (EMR). They’ve been using the
EMR for quite a while, and they’ve developed
an initiative with ICW (InterComponentWare,
Inc.), a German software company, that uses
ICW’s Personal Health Record (PHR) called
LifeSensor. They’re working on developing an
interoperability platform between their EMR
and ICW’s PHR, and the GE Centricity system.
Right now I believe they have a pilot pro-
gram with a thousand patients enrolled. It
looks like they’re going to get some very posi-
tive benefits and they’re quite excited about it.
Again, the goal is to be able to facilitate better
communication and interaction with patients
and to really engage patients.
One of the tools they offer that apparently is
resonating well with patients is an interactive
tool that patients can use to compute their heart
age. A patient can enter various pieces of data
into the tool and, based on that data and the
patient’s chronologic age, the tool will calcu-
late the age of the patient’s heart. They said that
this really motivates patients because they can
actually change the variables and see the effect.
For example, a patient can calculate his or her
heart age based on a cholesterol level of 250.
Then he or she can lower the cholesterol level
to 190 and see how the heart age is affected. By
changing the data patients can see how, if they
just make some minor modifications here and
there, those changes could have a big effect. It
really motivates their patients.
The next session was “Consumer Education
on the Internet,” presented by Michael O’Neil
of GetWellNetwork and Charlyn Slade of 
TLContact, Inc. I thought Michael O’Neil was
brilliant and an interesting guy. He had been a
health care consumer himself. He had a signif-
icant personal illness and had spent a large
amount of time as an inpatient in the hospital
fighting a cancer diagnosis. He talked about
how he felt totally unempowered during the
whole process—like he wasn’t an active par-
ticipant at all. Once he got out of the hospital
he decided to do something to change that. He
formed a company that focuses on consumer
education in the inpatient setting; Thomas Jef-
ferson University Hospital is piloting the whole
system that he has developed. The system
works on the TV monitors in patients’ rooms.
It’s programmed to allow a certain amount
of time between interactions and then will au-
tomatically key up, even if the patient is watch-
ing TV. The system interrupts and poses a
question and asks the patient to respond. It en-
courages the patient to proceed with certain ed-
ucational activities.
Or, for instance, it will ask the patient to rate
his or her pain. It may just pop up in the mid-
dle of a TV program and ask the patient to rate
his or her pain on a scale from 1–10. If the pa-
tient says that they’re in a moderate or severe
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amount of pain, the system automatically sends
an alert back to the nurse’s station.
I thought that was really a neat thing to see.
Here again, you can see how that could help
motivate patients, help improve communica-
tion, and streamline the process within the hos-
pital setting.
Charlyn Slade talked about a program called
“Care Pages,” which is being piloted at the Uni-
versity of Pennsylvania. It’s a system where pa-
tients with significant illnesses actually de-
velop their own unique Web pages. This can be
used to foster communication not only between
care providers and that patient, but it also al-
lows community and family members to com-
municate with that patient. It offers the ability
to sign on and find out the status of the patient,
if the patient has given consent.
It’s a way to foster communication in the
provider setting as well as with the family to
help build the social support that’s needed
around fighting an illness. Ms. Slade talked
about how certain family members sometimes
can actually receive a lot of support from
friends and family as they’re trying to help
their loved one through a prolonged illness.
The last session was “Online Peer Coaching”
and this was conducted by Neal Sofian of The
NewSof Group. I thought he was quite enter-
taining as a speaker and very enjoyable to lis-
ten to. His presentation was more about soci-
ology than medicine, and he made a lot of great
points.
He talked about the fact that learning is so-
cial; it’s about identifying the “me” and then
finding people who are like you who have had
like experiences and learning from those peo-
ple. One of the things he said is that you learn
from the stories of the group. That’s really how
you learn.
He talked about a concept called “microcul-
tures of meaning,” which he termed “MOM.”
He started out his talk by saying, “By the end
you’ll understand—the crucial point is always
listen to your MOM.” And by the end, you un-
derstood what MOM was.
Basically MOM is a community of people
with common needs and a common purpose.
By developing those—using online tools to ac-
tually have discussion groups and blogs—peo-
ple who are going through similar experiences
have a way to share their learning and build
camaraderie.
Another memorable thing he said was, “So-
cieties construct the lenses through which their
members see the world.” And basically you can
do this by developing these microcultures on
line.
He also talked about the way these micro-
cultures can be used by disease management
companies to have members participate in on-
line discussions that are monitored by a health
care provider. It’s another way of motivating
people, but in an online group concept.
I think that’s pretty much it for our group.
Dr. Nash: Thanks, Don, for that outstanding
overview of the program. We appreciate your
help in bringing it to the public.
Now, let’s hear from Dr Leider.
Harry Leider, MD, MBA: My section was led
off by a presentation by myself and Laurie Rus-
sell, our Senior Director of Health Solutions 
at XLHealth. It was entitled “Disease Man-
agement in Medicare—Early Lessons from
Medicare Health Support and Chronic Care
Special Needs Plans.”
In this session, Laurie and I outlined the con-
structs or the conceptual models behind both
Medicare Health Support and our program in
Tennessee, as well as the models that are evolv-
ing around Chronic Care Special Needs Plans.
We went over the legislation that enabled that
to happen via the Medicare Modernization Act
and the catalyzing event of Medicare moving
to risk-adjusted payments that were fully im-
plemented in 2007.
Laurie then went into some of the key dis-
ease management and complex case manage-
ment competencies that are needed to manage
a population that consists 100% of chronically
ill seniors. We shared what we called the Six
Competencies for launching and implementing
a Chronic Care Special Needs Plan and some
early lessons learned from Medicare Health
Support.
The bottom line in both of these presenta-
tions is that rapidly engaging members or pa-
tients, getting them involved, and having an ef-
fective disease and case management program
are the keys to success in both the Chronic Care
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Special Needs Plans and Medicare Health Sup-
port.
It’s too early to really know for sure how
we’re doing in the Medicare Health Support
Program, and for that matter, it’s probably the
same for all the vendors for Medicare Health
Support.
Our presentation was followed by Dr. Patri-
cia Salber from PRS Strategic Healthcare Con-
sulting. She reviewed her experience as a lead
consultant for an insurance company that has
launched a very innovative and rapidly grow-
ing private fee-for-service Medicare plan.
She educated the audience about how pri-
vate fee-for-service Medicare plans work. In
her view, they are a compromise between the
fee-for-service Medicare model and the more
traditional Medicare HMOs that are more re-
strictive. They cover some of the out-of-pocket
charges that traditional Medicare burdens the
beneficiary with. They are starting to put in
place a case and disease management infra-
structure to offer some care management on
top of the fee-for-service network.
The plan that she was working with—I be-
lieve it was America Universal—has grown
very, very rapidly—in just 4 or 5 months it
grew from a handful of members to, I believe,
170,000 seniors in multiple states. The biggest
challenge is developing the infrastructure and
outsourcing relationships to do the health care
risk assessments, coaching calls, and disease
management interventions that they are trying
to put in place for this membership. There are
no financial or clinical results yet, but there is
a lot of interesting information about how at-
tractive this model is to seniors across the coun-
try.
That session was followed by two presenta-
tions about Pay-for-Performance (P4P) within
disease management programs. The first talk
was by James Hardy, the former Deputy Sec-
retary from the Office of Medical Assistance
Programs of the Commonwealth of Pennsyl-
vania. He’s the current president of the Sellers
Feinberg organization.
He reviewed the experience in Pennsylvania
with their Access Plus Medicaid program. In
the State of Pennsylvania, there is a mandated
managed Medicaid program that largely cen-
ters around Pittsburgh and Philadelphia. But in
the more rural areas of the State, the so-called
T-Zone (across the north and down the center
of the state), there is a second network where
there is no managed Medicaid—instead, it’s an
enhanced fee-for-service network.
In that region, Pennsylvania hired a disease
management vendor to put in place a disease
management program for certain diseases, as
well as to put in place a provider pay-for-per-
formance model. The model has 3 tiers of pay-
ments to doctors, largely focused on the pri-
mary care provider.
Essentially, the first tier is for engaging the
doctor to help enroll Medicaid members into
the disease management program. The second
tier is for selected clinical process measures—
for example, whether the patient is on a par-
ticular medication for asthma or for heart fail-
ure. The third tier is for actual clinical
outcomes.
Mr. Hardy said it was a little early to know
for sure the impact of the program, but the ini-
tial analysis is very positive and they have gone
back to the Commonwealth for more funding
for future P4P programs because they believe
that the 600 primary care doctors who signed
up for P4P (out of the 2,100 in their network)
are achieving a higher quality of care than are
the primary care doctors who did not sign up
for P4P. So they saw this as a very positive ini-
tial outcome, and worthwhile to ask the State
to invest more in this strategy.
Interestingly enough, the next presentation
was by Dr. Gus Geraci, who is the Pennsylva-
nia Medical Director for AccessPlus for
McKesson, the vendor of the program outlined
by Mr. Hardy. Dr. Geraci described his point of
view of the program from the vendor’s stand-
point. He basically agreed with Jim Hardy that
the program—although it had some imple-
mentation issues—was well received by the
doctors and had some encouraging outcomes
data for the 600 doctors who participated.
He was less able to quantify the impact of
this P4P program in the Medicare Health Sup-
port Program in Mississippi, where it was im-
plemented, because of hurricane Katrina. Due
to this catastrophe, the impact of any programs
implemented in Mississippi was limited as en-
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rollees in the Medicare Health Support Pro-
gram were dealing with a crisis rather than
their disease-related issues. More recently,
McKesson has dropped out of the Medicare
Health Support Program. In summary, Dr.
Geraci’s program was a recapitulation and a
validation of the prior P4P comments made by
Jim Hardy.
It was a great afternoon session with a lot
of good discussion and provocative topics. I
think the general tone of the session validates
my view that there is a lot of enthusiasm for
disease management as a solution to many of
the problems in the Medicare and Medicaid
sectors, and there is a lot of government fo-
cus and a lot of interest in this very powerful
tool.
Dr. Nash: Great, Harry. Thank you. And now,
Tracey Moorhead, please tell us about the ses-
sion you moderated.
Tracey Moorhead: I moderated a panel, rather
than a track, and my panel comprised Chief
Medical Officers from leading organizations
within the disease management community.
The panelists included Dr. Ron Loeppke from
Matria; Dr. Richard Popiel from Horizon Blue
Cross Blue Shield of New Jersey; Dr. Phil Ben-
ditt from United HealthCare; Dr. Charles Peck
from Take Care Health Systems; Dr. Ray Fabius
from CHD Meridian and I-trax, and Dr. Jan
Berger from CVS Caremark.
We began the panel by inviting each of the
panelists to give a quick overview of what they
felt to be some of the most pressing issues con-
fronting the industry today, and then engaged
in a series of questions and answers and dis-
cussion among the panelists.
I will say that, in reviewing my notes on the
panel, I was struck by 3 or 4 very clear themes
into which we could break down the panel dis-
cussion.
First, there was a broad agreement that the
current definition of disease management
should be expanded to include prevention and
wellness activities, given the expanse of pro-
gramming within disease management organi-
zations that reflects the full continuum of care
and the services all along that continuum. Sec-
ond, we focused on engagement issues in the
context of employees and other consumers and
physicians. In discussing consumer engage-
ment, both in the employer setting at the work-
place and outside the employer setting at other
touch points, panelists generally agreed that, as
Dr. Loeppke stated, disease management is not
quite on the verge of a direct-to-consumer, re-
tail model. This will not be the case until con-
sumers see clear financial incentives for partic-
ipation in these types of care and wellness
programs.
There was great interest in discussion of
workplace clinic settings. In particular, Dr.
Fabius, of CHD Meridian, mentioned that their
studies have found employee engagement in
companies with workplace clinics to be 3 to 5
times greater than engagement in other work-
place settings. It was very interesting to hear
the various opinions on consumer engagement
touch points.
With regard to physician engagement, the
general consensus was that disease manage-
ment has not yet focused enough attention or
resources on full-scale physician engagement.
Although this is changing, it requires addi-
tional focus on the part of the health, disease,
and care management communities. That was
stated by Dr. Benditt, and the other panelists
concurred.
In response to a question on this issue, the
panelists seemed to concur that there is great
opportunity for partnerships between physi-
cians and the disease management model—
both through integration of data and integra-
tion of multiple services. The panelists agreed,
however, that there are major health policy
challenges regarding reimbursement to physi-
cians that need to be addressed and overcome
before the medical home model, the disease
management model, and direct-to-physician
engagement can truly succeed.
There also was agreement that physicians
should view disease management as support-
ive and collaborative, and that the industry
needs to focus on promoting systems connec-
tivity and automation to physicians. This is per-
haps the best gift disease management has to
offer physicians: to help them better under-
stand how disease management can ease their
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workload and streamline their workflow pro-
cesses.
A third broad theme of discussion revolved
around integration, both along the contin-
uum—the various programs offered by disease
management organizations—and among care
providers—doctors, hospitals, and other care
settings. There was general discussion about
the integration of these programs as a business
model to ensure that purchasers understand
the need for interaction among these various
programs.
A final area of general discussion was the
value of investments and how to articulate to
employers and other purchasers the very im-
portant value disease management services
provide. Dr. Fabius likened employees to
skilled athletes and suggested that employers,
like sports team owners, can improve perfor-
mance and achieve business goals by helping
employees manage health and avoid illness.
Dr. Loeppke stated that the number one bur-
den for employers is the burden of risk and ill-
ness. Communicating the value of investment
and the emphasis on an integrated return on
investment, rather than on siloed program re-
turn on investment, represents an enormous
opportunity for the disease management com-
munity.
There also was discussion regarding the
need to establish valid return on investment
measures for health and wellness programs, as
that is an area of great interest to employers.
The industry needs to move forward to de-
velop those valid measurement tools that will
help employers understand the ultimate value
of these types of programs.
There were discussions about other out-
comes measures now under way, and a series
of exchanges about other benefits to physicians
in the medical home model.
Overall, I thought it was a great discussion
with highly engaging conversation and contri-
butions from the panelists.
Dr. Nash: Thank you, Tracey. Tine Hansen-
Turton moderated and presented at the track
entitled “Disease Management in the Commu-
nity Setting.” Tine, please give us a brief sum-
mary of your track.
Tine Hansen-Turton, MGA: We had 3 differ-
ent types of presentations in our panels. The
first one was on “Convenient Care” clinics, pre-
sented by Dr. Chuck Peck from Take Care
Health Systems. He did an outstanding job of
laying out the landscape of convenient care
clinics, the scope of practice within the clinics,
and what potentially is the avenue for more
disease management services within that
sphere for the type of providers in the com-
munity.
I made a brief presentation on the “Nurse-
Managed Health Centers.” I talked more about
how to utilize them as safety net providers,
what they’re doing in the disease management
area, and obviously with the idea that they ac-
tually are open to research—it would be a great
way to do additional work on such communi-
ties in the country.
The next speaker was Dr. Jeffrey Brenner
from the Department of Family Medicine at the
Robert Wood Johnson Medical School-Cam-
den. He talked about an innovative approach
of trying to bring health care providers together
in an area like Camden to promote better uni-
formity, better communication among physi-
cians and other providers, and to provide bet-
ter customer and consumer care.
The next presentation, by Carole DeSpain
Magoffin of National Minority Quality Forum,
was on disease management zip-code map-
ping, which I thought was phenomenal in the
sense that the more we can have data mapped,
the better we’ll be able to do health care policy
as well as look at streamlining programs in cer-
tain areas. It was very impressive from a big-
policy perspective. The kind of data available
from a mapping structure would be very ben-
eficial to all of us as we plan—whether it’s for
disease management or any other health care
issue in this country.
Overall, I thought there was good discussion.
Our panel dealt with many different topics, but
the overarching theme was how to provide ac-
cessible disease management services in dif-
ferent settings. There was good feedback from
everybody there.
Dr. Nash: Thank you, Tine. Well, the 4 of you
have set a high bar. Now let me try to sum-
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marize the final session, which I had the priv-
ilege of chairing. It was the CEO Panel called
“Charting the Road Ahead.”
As with Tracey’s session, these were not mul-
tiple presentations, but rather a series of ques-
tions posed by me to the CEOs. There were 4
members on the panel: Dr. George Bennett
from Health Dialog; Frank Martin from I-trax;
Dr. Sandeep Wadhwa (sitting in for Emad
Rizk) from McKesson, and Dr. Earl Steinberg
from Resolution Health.
We covered a broad number of topics. I’ll try
to hit the highlights and where there was some
controversy. One question concerned what the
panel members see as the future of Pay for Per-
formance (P4P). As you might expect, the CEOs
were energized by P4P. They were wary of
some of the measurement issues but, generally
speaking, felt it would be a net gain for the dis-
ease management industry as the programs
that they represent and promote would go a
long way toward improving overall health sta-
tus.
We had some discussion about the future of
information technology challenges. Again, as
expected, the CEOs were unanimous in saying
that they all had comprehensive challenges
within information technology, including such
basic things as appropriate linking of lab re-
sults, to more comprehensive activities such as
Resolution Health evaluating various prescrib-
ing habits of clinicians and being able to give
the clinicians feedback about how well they
were tracking these guidelines.
One area of some controversy was the ques-
tion of whether or not we should create an ac-
creditation or certification pathway within
DMAA for nurses and others in the field of dis-
ease management. Surprisingly, all 4 CEOs
were quite negative about the idea of an ac-
creditation commission or certification exami-
nation.
Their critique focused on such things as time-
liness, changes in the field happening at a rapid
pace, the view of accreditation from outsiders,
and introducing bias into the examination pro-
cess and related activities. They were uni-
formly opposed to any kind of accreditation or
certification within disease management.
Another area we discussed, like some of the
other panel members, was Medicare Health
Support. The panelists were wary of what some
of the current results coming from Medicare
Health Support look like, but all expressed
great hope that Medicare Health Support
would be successful in the future, recognizing
that Congress could be readily swayed by some
of the early published results coming from the
program.
We spent some time talking about a research
agenda for disease management. While all 4
leaders are in favor of a research agenda, I
would say they were tepid with regard to any
kind of private sector funding for research. I-
trax, in particular, was enthusiastic about their
own research agenda, with multiple articles
coming to Disease Management and others in the
pipeline. The other CEOs felt it was important
but, outside of I-trax, I certainly would not put
research in their top 3 areas of priority.
We had some discussion about the future
supply of primary care physicians and the pos-
sible impact of that on disease management. All
4 CEOs were very current in their knowledge
regarding the potential future shortage of pri-
mary care doctors. They called for an expan-
sion in nurse practitioner scope of practice.
While they had no ready solution for improv-
ing the supply of primary care doctors, they
did acknowledge the medical school challenges
in helping students to pick careers in primary
care, especially regarding the high debt in-
curred by the time students graduate from
medical school and the long-term lower antic-
ipated average income as compared to special-
ists.
Finally, I asked the panel members what ad-
vice they would give an incoming US President
about the health care system.
I was very happy to hear that, across the
board, the 4 leaders called for a greater em-
phasis on prevention, wellness, and screening,
and an end to diverting so many resources to
quaternary care. We bemoaned the fact that
Medicare pays for bariatric surgery but doesn’t
pay for nutrition counseling, or the time a doc-
tor spends helping a patient with diabetes bet-
ter understand the pathophysiology of their
disease. So, all 4 felt that a Presidential candi-
date would really need to sit and listen care-
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fully about the need for greater emphasis on
prevention and coordination of care. All were
quick to point out that the current payment sys-
tem is nothing short of toxic, and that if you
pay doctors to do piecework, you can only ex-
pect more piecework.
In summary, I’d say it was a great panel. The
CEOs were not provided with the questions
ahead of time. It made for aspects of live tele-
vision and, despite their professed nervous-
ness, all were very articulate and there were
outstanding questions from the floor at the con-
clusion of the program.
Once again, I really appreciate all of you tak-
ing the time to join me in recapping the high-
lights of the colloquium.
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